The results indicated that the utilization of medicinal and food homologous substances exhibited a significant improvement in serum lipid levels (TC, TGs, LDL-C, and HDL-C), FBG, as well as liver enzymes (ALT and AST) among patients diagnosed with NAFLD. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.